nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisatracurium Besylate—Generalised erythema—Cisplatin—germ cell cancer	0.134	0.188	CcSEcCtD
Cisatracurium Besylate—CHRND—pericardium—germ cell cancer	0.129	0.449	CbGeAlD
Cisatracurium Besylate—Trauma—Bleomycin—germ cell cancer	0.0319	0.0447	CcSEcCtD
Cisatracurium Besylate—Hypoxemia—Methotrexate—germ cell cancer	0.0306	0.0429	CcSEcCtD
Cisatracurium Besylate—Hypoxia—Ifosfamide—germ cell cancer	0.0204	0.0286	CcSEcCtD
Cisatracurium Besylate—Wheezing—Bleomycin—germ cell cancer	0.0147	0.0207	CcSEcCtD
Cisatracurium Besylate—CHRNB1—eye—germ cell cancer	0.0145	0.0503	CbGeAlD
Cisatracurium Besylate—Laryngospasm—Etoposide—germ cell cancer	0.0137	0.0192	CcSEcCtD
Cisatracurium Besylate—Injury—Bleomycin—germ cell cancer	0.012	0.0168	CcSEcCtD
Cisatracurium Besylate—Cardiovascular disorder—Etoposide—germ cell cancer	0.0117	0.0164	CcSEcCtD
Cisatracurium Besylate—Azotaemia—Methotrexate—germ cell cancer	0.0115	0.0162	CcSEcCtD
Cisatracurium Besylate—Wheezing—Cisplatin—germ cell cancer	0.0109	0.0152	CcSEcCtD
Cisatracurium Besylate—CHRNA1—endocrine gland—germ cell cancer	0.0108	0.0375	CbGeAlD
Cisatracurium Besylate—CHRNA1—head—germ cell cancer	0.0106	0.037	CbGeAlD
Cisatracurium Besylate—CHRNB1—medulla oblongata—germ cell cancer	0.0104	0.0361	CbGeAlD
Cisatracurium Besylate—Hypoxia—Methotrexate—germ cell cancer	0.00966	0.0135	CcSEcCtD
Cisatracurium Besylate—CHRNB1—adrenal gland—germ cell cancer	0.00959	0.0334	CbGeAlD
Cisatracurium Besylate—CHRNB1—midbrain—germ cell cancer	0.00946	0.033	CbGeAlD
Cisatracurium Besylate—Bronchospasm—Bleomycin—germ cell cancer	0.00936	0.0131	CcSEcCtD
Cisatracurium Besylate—CHRNB1—spinal cord—germ cell cancer	0.00923	0.0322	CbGeAlD
Cisatracurium Besylate—Cardiac arrest—Ifosfamide—germ cell cancer	0.00895	0.0126	CcSEcCtD
Cisatracurium Besylate—CHRNB1—female gonad—germ cell cancer	0.00894	0.0311	CbGeAlD
Cisatracurium Besylate—CHRNA2—endocrine gland—germ cell cancer	0.00893	0.0311	CbGeAlD
Cisatracurium Besylate—CHRNA2—head—germ cell cancer	0.00882	0.0307	CbGeAlD
Cisatracurium Besylate—Anaphylactoid reaction—Cisplatin—germ cell cancer	0.00838	0.0118	CcSEcCtD
Cisatracurium Besylate—CHRNB1—head—germ cell cancer	0.00821	0.0286	CbGeAlD
Cisatracurium Besylate—Bronchospasm—Ifosfamide—germ cell cancer	0.008	0.0112	CcSEcCtD
Cisatracurium Besylate—CHRNB1—testis—germ cell cancer	0.00793	0.0276	CbGeAlD
Cisatracurium Besylate—CHRNA2—cerebellum—germ cell cancer	0.00787	0.0274	CbGeAlD
Cisatracurium Besylate—CHRNA1—brain—germ cell cancer	0.0077	0.0268	CbGeAlD
Cisatracurium Besylate—Anaphylactoid reaction—Etoposide—germ cell cancer	0.00768	0.0108	CcSEcCtD
Cisatracurium Besylate—CHRNB1—cerebellum—germ cell cancer	0.00732	0.0255	CbGeAlD
Cisatracurium Besylate—Flushing—Bleomycin—germ cell cancer	0.00707	0.00992	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Etoposide—germ cell cancer	0.00707	0.00992	CcSEcCtD
Cisatracurium Besylate—Convulsion—Vinblastine—germ cell cancer	0.0068	0.00954	CcSEcCtD
Cisatracurium Besylate—Hypertension—Vinblastine—germ cell cancer	0.00678	0.00951	CcSEcCtD
Cisatracurium Besylate—Erythema—Bleomycin—germ cell cancer	0.00663	0.0093	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Ifosfamide—germ cell cancer	0.00663	0.0093	CcSEcCtD
Cisatracurium Besylate—Flushing—Dactinomycin—germ cell cancer	0.00659	0.00925	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Ifosfamide—germ cell cancer	0.0064	0.00898	CcSEcCtD
Cisatracurium Besylate—CHRNA2—brain—germ cell cancer	0.00639	0.0223	CbGeAlD
Cisatracurium Besylate—Bronchospasm—Etoposide—germ cell cancer	0.00632	0.00887	CcSEcCtD
Cisatracurium Besylate—Erythema—Dactinomycin—germ cell cancer	0.00619	0.00868	CcSEcCtD
Cisatracurium Besylate—Flushing—Ifosfamide—germ cell cancer	0.00604	0.00848	CcSEcCtD
Cisatracurium Besylate—CHRNB1—brain—germ cell cancer	0.00595	0.0207	CbGeAlD
Cisatracurium Besylate—Angiopathy—Ifosfamide—germ cell cancer	0.00591	0.00829	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Ifosfamide—germ cell cancer	0.00588	0.00825	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00587	0.00823	CcSEcCtD
Cisatracurium Besylate—CHRNB1—lymph node—germ cell cancer	0.00575	0.02	CbGeAlD
Cisatracurium Besylate—Bradycardia—Cisplatin—germ cell cancer	0.00571	0.00802	CcSEcCtD
Cisatracurium Besylate—Erythema—Ifosfamide—germ cell cancer	0.00567	0.00795	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Cisplatin—germ cell cancer	0.00552	0.00774	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Bleomycin—germ cell cancer	0.00541	0.00759	CcSEcCtD
Cisatracurium Besylate—Flushing—Cisplatin—germ cell cancer	0.00521	0.00731	CcSEcCtD
Cisatracurium Besylate—Angioedema—Ifosfamide—germ cell cancer	0.00518	0.00727	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Cisplatin—germ cell cancer	0.00507	0.00711	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Cisplatin—germ cell cancer	0.00506	0.0071	CcSEcCtD
Cisatracurium Besylate—Hypotension—Bleomycin—germ cell cancer	0.00506	0.0071	CcSEcCtD
Cisatracurium Besylate—Convulsion—Ifosfamide—germ cell cancer	0.00491	0.00689	CcSEcCtD
Cisatracurium Besylate—Hypertension—Ifosfamide—germ cell cancer	0.00489	0.00687	CcSEcCtD
Cisatracurium Besylate—Erythema—Cisplatin—germ cell cancer	0.00489	0.00686	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Bleomycin—germ cell cancer	0.00483	0.00677	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00479	0.00672	CcSEcCtD
Cisatracurium Besylate—Flushing—Etoposide—germ cell cancer	0.00477	0.0067	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Vinblastine—germ cell cancer	0.00472	0.00662	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Etoposide—germ cell cancer	0.00467	0.00655	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Etoposide—germ cell cancer	0.00465	0.00652	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Etoposide—germ cell cancer	0.00463	0.0065	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00463	0.00649	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.0046	0.00645	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Ifosfamide—germ cell cancer	0.00454	0.00636	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Ifosfamide—germ cell cancer	0.00449	0.0063	CcSEcCtD
Cisatracurium Besylate—Hypotension—Ifosfamide—germ cell cancer	0.00432	0.00606	CcSEcCtD
Cisatracurium Besylate—Urticaria—Bleomycin—germ cell cancer	0.0043	0.00603	CcSEcCtD
Cisatracurium Besylate—Convulsion—Cisplatin—germ cell cancer	0.00423	0.00594	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00413	0.0058	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Ifosfamide—germ cell cancer	0.00412	0.00579	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Cisplatin—germ cell cancer	0.00399	0.00559	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Bleomycin—germ cell cancer	0.00399	0.00559	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Cisplatin—germ cell cancer	0.00391	0.00549	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Cisplatin—germ cell cancer	0.00389	0.00546	CcSEcCtD
Cisatracurium Besylate—Convulsion—Etoposide—germ cell cancer	0.00388	0.00544	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Cisplatin—germ cell cancer	0.00387	0.00543	CcSEcCtD
Cisatracurium Besylate—Hypertension—Etoposide—germ cell cancer	0.00387	0.00542	CcSEcCtD
Cisatracurium Besylate—Pruritus—Bleomycin—germ cell cancer	0.00383	0.00537	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00379	0.00531	CcSEcCtD
Cisatracurium Besylate—Hypotension—Cisplatin—germ cell cancer	0.00373	0.00523	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Dactinomycin—germ cell cancer	0.00372	0.00522	CcSEcCtD
Cisatracurium Besylate—Urticaria—Ifosfamide—germ cell cancer	0.00368	0.00516	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Etoposide—germ cell cancer	0.00365	0.00513	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Etoposide—germ cell cancer	0.00357	0.005	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Cisplatin—germ cell cancer	0.00356	0.00499	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Etoposide—germ cell cancer	0.00355	0.00498	CcSEcCtD
Cisatracurium Besylate—Hypotension—Etoposide—germ cell cancer	0.00341	0.00479	CcSEcCtD
Cisatracurium Besylate—Rash—Bleomycin—germ cell cancer	0.00341	0.00479	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Bleomycin—germ cell cancer	0.00341	0.00478	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Ifosfamide—germ cell cancer	0.00341	0.00478	CcSEcCtD
Cisatracurium Besylate—Pruritus—Ifosfamide—germ cell cancer	0.00327	0.00459	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Etoposide—germ cell cancer	0.00326	0.00457	CcSEcCtD
Cisatracurium Besylate—Rash—Dactinomycin—germ cell cancer	0.00318	0.00447	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Cisplatin—germ cell cancer	0.00294	0.00412	CcSEcCtD
Cisatracurium Besylate—Rash—Ifosfamide—germ cell cancer	0.00292	0.00409	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Ifosfamide—germ cell cancer	0.00291	0.00409	CcSEcCtD
Cisatracurium Besylate—Urticaria—Etoposide—germ cell cancer	0.0029	0.00407	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Methotrexate—germ cell cancer	0.00279	0.00392	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Methotrexate—germ cell cancer	0.00278	0.0039	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Methotrexate—germ cell cancer	0.00278	0.00389	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Etoposide—germ cell cancer	0.00269	0.00378	CcSEcCtD
Cisatracurium Besylate—Erythema—Methotrexate—germ cell cancer	0.00268	0.00376	CcSEcCtD
Cisatracurium Besylate—Pruritus—Etoposide—germ cell cancer	0.00259	0.00363	CcSEcCtD
Cisatracurium Besylate—Rash—Cisplatin—germ cell cancer	0.00251	0.00353	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Cisplatin—germ cell cancer	0.00251	0.00352	CcSEcCtD
Cisatracurium Besylate—Convulsion—Methotrexate—germ cell cancer	0.00232	0.00326	CcSEcCtD
Cisatracurium Besylate—Rash—Etoposide—germ cell cancer	0.0023	0.00323	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Etoposide—germ cell cancer	0.0023	0.00323	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00227	0.00318	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Methotrexate—germ cell cancer	0.00219	0.00307	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Methotrexate—germ cell cancer	0.00215	0.00301	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Methotrexate—germ cell cancer	0.00213	0.00298	CcSEcCtD
Cisatracurium Besylate—Hypotension—Methotrexate—germ cell cancer	0.00205	0.00287	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Methotrexate—germ cell cancer	0.00195	0.00274	CcSEcCtD
Cisatracurium Besylate—Urticaria—Methotrexate—germ cell cancer	0.00174	0.00244	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Methotrexate—germ cell cancer	0.00161	0.00226	CcSEcCtD
Cisatracurium Besylate—Pruritus—Methotrexate—germ cell cancer	0.00155	0.00217	CcSEcCtD
Cisatracurium Besylate—Rash—Methotrexate—germ cell cancer	0.00138	0.00194	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Methotrexate—germ cell cancer	0.00138	0.00193	CcSEcCtD
